NEVVI Medicare utilization intelligence

← back

Provider profile

PATEL, AKASH M. D.

Dermatology · NPI 1811955792 · GARLAND, TX

2
Groups
36
Codes · 2024
14,292
Disclosed services

PATEL, AKASH is a Dermatology in GARLAND, TX, a member of 2 medical groups, who billed 36 distinct codes to Medicare Part B in 2024.

Groups: PDP OF TEXAS, PLLC (PLANO, TX) · UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS (DALLAS, TX) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

14,292
disclosed services
36
codes billed to Medicare Part B
Prior year · CY2023 14,081 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
17110 Destruction of skin growth, 1-14 growths premiumpremium premiumpremium
17000 Destruction of precancer skin growth, 1 growth premiumpremium premiumpremium
17004 Destruction of precancer skin growth, 15 or more growths premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
96910 Therapy procedure using ultraviolet radiation with tar or petroleum jelly application premiumpremium premiumpremium
11102 Biopsy of related skin growth, first growth premiumpremium premiumpremium
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
11103 Biopsy of related skin growth, each additional growth premiumpremium premiumpremium
17263 Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm premiumpremium premiumpremium
11301 Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm premiumpremium premiumpremium
11311 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm premiumpremium premiumpremium
11307 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm premiumpremium premiumpremium
11306 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm premiumpremium premiumpremium
17273 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm premiumpremium premiumpremium
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm premiumpremium premiumpremium
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm premiumpremium premiumpremium
11312 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm premiumpremium premiumpremium
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm premiumpremium premiumpremium
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm premiumpremium premiumpremium
69100 Biopsy of ear premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
13122 Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less premiumpremium premiumpremium
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm premiumpremium premiumpremium
11200 Removal of skin tag, 1-15 skin tags premiumpremium premiumpremium
11901 Injection into skin growth, more than 7 growths premiumpremium premiumpremium
11303 Shaving of skin growth of body, arms, or legs, more than 2.0 cm premiumpremium premiumpremium
11623 Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm premiumpremium premiumpremium
17111 Destruction of skin growth, 15 or more growths premiumpremium premiumpremium
10061 Complicated or multiple drainage of skin abscess premiumpremium premiumpremium
17283 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm premiumpremium premiumpremium
11643 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.